Compound Profiles
GHRP-2
Growth Hormone Releasing Peptide-2 | Pralmorelin
GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.
HGH
Human Growth Hormone | Somatropin
Binds to GH receptors on target tissues, triggering JAK2-STAT5 signaling pathway. Direct effects include lipolysis, protein synthesis, and metabolic regulation.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take GHRP-2 with HGH?
Yes, but timing matters. GH secretagogues and exogenous GH compete via negative feedback. Exogenous GH suppresses natural GH pulses, reducing secretagogue efficacy. If combining, administer the secretagogue first and separate by 2+ hours. Administer secretagogue 2+ hours before exogenous GH
Is GHRP-2 and HGH safe together?
Based on pharmacological analysis, this combination is considered timing required. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between GHRP-2 and HGH?
GH secretagogues and exogenous GH compete via negative feedback. Exogenous GH suppresses natural GH pulses, reducing secretagogue efficacy. If combining, administer the secretagogue first and separate by 2+ hours. Timing guidance: Administer secretagogue 2+ hours before exogenous GH. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time GHRP-2 and HGH?
GHRP-2 has a half-life of ~30 minutes and HGH has a half-life of 3-4 hours (SC), 20-30 minutes (IV). Administer secretagogue 2+ hours before exogenous GH
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.